ECRG1 and its relationship with esophageal cancer: A brief review

Onkologie

Volumn 36, Issue 4, 2013, Pages 213-216

  Rasool, Sabha ^a   Khan, Tanzeela ^a   Qazi, Falak ^a   Ganai, Bashir A ^a  

^a UNIVERSITY OF KASHMIR   (India)

Author keywords

ECRG1; Esophageal cancer; Esophageal squamous cell carcinoma

Indexed keywords

ESOPHAGEAL CANCER RELATED GENE 1; ONCOPROTEIN; UNCLASSIFIED DRUG;

CATALYSIS; DNA POLYMORPHISM; ESOPHAGUS CANCER; EXON; GENETIC SUSCEPTIBILITY; HUMAN; ONCOGENE; REVIEW;

ESOPHAGEAL NEOPLASMS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SERINE PROTEASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84876198494     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000349960     Document Type: Review

References (24)

1. Su T, Liu H, Lu S: Cloning and identification of cDNA fragments related to human esophageal cancer. Chin J Oncol 1998;20:254-257.
2. Netzel-Arnett S, Hooper JD, Szabo R, et al.: Membrane anchored serine proteases: a rapid expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev 2003;22:237-258.
3. Barrett MT, Sanchez CA, Galipeau PC, Neshat K, Emond M, Reid BJ: Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrette's esophagus. Oncogene 1996;13:1867-1873.
4. Perona JJ, Craik CS: Structural basis of substrate specificity in the serine proteases. Protein Sci 1995;4:337-360.
5. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al.: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 2004;36:40-45.
6. Wang Y, Wang J, Liu H, Tang H, Guo L, Lu SH: ECRG1, a novel esophageal gene, cloned and identified from human esophagus and its inhibition effect on tumors. Carcinogenesis 2008;29:157-160.
7. Zhao N, Wang J, Cui Y, Guo L, Lu S: Induction of G1 cell cycle arrest and P15INK4b expression by ECRG1 through interaction with Miz-1. J Cell Biochem 2004;92:65-76.
8. Kunisaki C, Shimada H, Akiyama H, Nomura M, Matsuda G, Ono H: Prognostic factors in esophageal cancer. Hepatogastroenterology 2004;51:736-740.
9. Zhao N, Huang G, Liping G, Lu S: ECRG1, a novel candidate of tumor supressor gene in the esophageal carcinoma, triggers a senescent program in NIHT3T3 Cells. Exp Biol Med 2005;231:84-90.
10. Lingner J, Cooper JP, Cech TR: Telomerase and DNA end replication: no longer a lagging strand problem. Science 1995;269:1533-1534.
11. Dhaene K, Van ME, Parwaresch R: Telomeres, telomerase and cancer: an update. Virchows Arch 2000;437:1-16.
12. Li C, Liang Y, Wu M, Xu L, Cai W: Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay. Chin Med J (Engl) 2002;115:1405-1408.
13. Shay JW, Zou Y, Hiyama E, Wright WE: Telomerase and cancer. Hum Mol Genet 2001;10:677-685.
14. Mitsui A, Kuwabara Y, Iwase H, et al.: Telomerase activity in esophageal squamous cell carcinoma: down-regulation by chemotherapeutic agent. J Surg Oncol 2002;79:37-45.
15. World Cancer Research Fund: Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington DC, World Cancer Research Fund-IARC, 1997, p 125.
16. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
17. Wu M, Zhao JK, Hu XS, Wang PH, Qin Y, Lu YC, Yang J, Liu AM, Mu DL, Veer PV: Association of smoking, alcohol drinking and dietary factors with esophageal cancer in high and low risk areas of Jiangsu Province China. World J Gastroenterol 2006;12:1686-1693.
18. Ginsberg GG, Fleischer DE: Tumors of the esophagus; in Long JD, Orlando RC (eds): Sleisenger and Fortdran's Gastrointestinal and Liver Diseases, ed 8, vol I. Saunders 2006, pp 949-978.
19. Zhou J, Zhao L Q, Xiong MM, Wang XQ, Yang GR, Qiu ZL, Wu M, Kiu ZH: Gene expression profiles at different stages of human esophageal squamous cell carcinoma. World J Gastroenterol 2003;9:9-15.
20. Leonhardt H, Cardoso MC: DNA methylation, nuclear structure, gene expression and cancer. J Cell Biochem Suppl 2000;(suppl 35):78-83.
21. Li Y, Zhang X, Huang G, Miao X, Guo L, Lin D, Lu SH: Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma. Carcinogenesis 2006;27:798-802.
22. Bachmann K, Shahmiri S, Kaifi J, Schurr P, Mann O, Rawnaq T, Block S, Kalinin V, Izbicki JR, Strate T: Polymorphism Arg290Arg in esophageal- cancerrelated gene 1 (ECRG1) is a prognostic factor for survival in esophageal cancer. J Gastrointest Surg 2009;13:181-187.
23. Rasool S, Ganai BA, Showkat AK, Ahanger AG, Qazi F, Khan T, Rasool V, Masood A: The ECRG1 290Arg/Gln polymorphism is associated with the risk of esophageal squamous cell carcinoma in Kashmir. Asian Pac J Cancer Prev 2011;12:265-269.
24. Liu H, Su T, Wang Y, Zhao X, Zhou C, Lu S: Cloning of new gene related to human esophageal carcinoma and its expression in the human esophageal carcinoma. Proc Am Assoc Cancer Res 1999;40:36.